Matthew Burke, Director and Principal Scientist at MSD, Trial Engagement Expert, Medical Executive Director of Genentech, Chief of Staff and Head of Clinical Strategy at Agenus, shared on LinkedIn:
“Wrapping up an incredible 10-day transatlantic journey focused on advancing cancer care in breast cancer and colorectal cancer (CRC).
It’s been a rewarding stretch of meaningful conversations, collaboration, and shared learning with colleagues and partners who are equally committed to improving outcomes for patients.
From exchanging insights to exploring new opportunities to move cancer care forward, this journey has reinforced the importance of collaboration across borders, disciplines, and communities.
Grateful for the connections made, the perspectives shared, and the collective commitment to turning innovation into meaningful impact for patients.
Heading home energized by what we can accomplish together—and excited for what comes next! Home for a few days”
Read other articles featuring Matthew Burke on OncoDaily.